drugset / Trial / NCT05312645

Diclofenac Gel in the Treatment of Cervicogenic Headache

NCT05312645

Phase 3 Withdrawn Loma Linda University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The intervention will consist of the nursing staff applying 2 grams of diclofenac 1% gel topically to the posterior cervical region four times daily. The control group will receive petroleum jelly topically to the posterior cervical region four times daily. Patients will receive a pre-intervention and post-intervention survey incorporating the Numeric Assessment Scale and Headache Impact Test-6.

Timeline

Start
2023-12
Primary completion
2024-08-21
Completion
2024-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 2 g Topical

Indications